Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Zhixiang Biology is a leading Chinese Contract Development and Manufacturing Organization (CDMO) specializing in biologics. Founded in 2018 and headquartered in Suzhou, the company provides end-to-end services from cell line development and process optimization to large-scale GMP manufacturing. It operates multiple production lines with capacities up to 5,000L and has attracted significant investment from top-tier firms like Hillhouse Capital and Sequoia China. The company focuses on accelerating the development of innovative therapies, including monoclonal antibodies, bispecifics, and recombinant proteins, for global pharmaceutical and biotech clients.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Zhixiang Medical Technology.